what are the potential side effects of glp-1 drugs long-term cancer Overdose risks increase as demand for injectable weight-loss on rise, research finds GLP-1 Medications: Everything You Need

These findings suggest that SGLT2i therapy may overall have more benefit than GLP-1 RA therapy in type 1 diabetes

The difference between lyophilized and liquid peptide formats also affects storage timelines and preparation requirements

Flash Glucose Monitoring Continues to Grow Despite the Presence of CGM Industry

Key Players In The Global GLP-1 Receptor Agonist Market Major companies operating in the glp-1 receptor agonist market are Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co

Preliminary data from early-phase trials have suggested promising weight reduction results

We also conducted subgroup analyses and meta-regressions on the treatment duration, single or dual/triple agonists, diabetes duration, age, and background hypoglycaemic treatments, to explore the effect of those modifiers on the findings